Delivery Order SPE2DR25D2001-SPE2DR26FBFP0
Award Date 11/20/25
Potential Completion Date 11/21/25
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,839.68 for Zonisade 100 mg/5 ml oral suspension (150 ml) on June 17, 2025, with completion scheduled for June 18, 2025. This non-competitive, firm fixed-price delivery order was issued under a child contract structure and performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,461.70 to AmerisourceBergen Drug Corp for the supply of Zonisade 100 mg/5 ml oral suspension in a 150 ml quantity. This firm fixed-price delivery order, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX. The contract was competitively awarded with no...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $7,958 to Amerisourcebergen Drug Corporation for Zonisade 100 mg/5 ml oral suspension. The contract has a period of performance from August 30, 2023 through August 31, 2023. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle...
- This federal contract award, valued at $11,573.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to deliver the medication Zonisade 100 mg/5 ml oral suspension in 150 ml bottles. This award is a delivery order under an Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical, which provides a wide range of medical commodities to support military treatment programs and facilities...
- This delivery order from the Defense Logistics Agency awards Amerisourcebergen Drug Corp $1,487.31 to supply 150ml of the oral suspension Zonisade 100 mg/5 ml. As the parent company, Amerisourcebergen Corporation will perform under the contract through its Corporate Office location in Conshohocken, Pennsylvania. The firm fixed price contract has an anticipated completion date of October 18, 2023 and did not utilize any set aside designations in the award. The Defense Logistics Agency supports...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the delivery of "ZONISADE 100 MG/5 ML ORAL SUSP 150ML", a pharmaceutical product, with a potential value of $2,155.73 and a completion date of February 29, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, through its...
- This federal contract award is for the delivery of the pharmaceutical product "ZONISADE 100 MG/5 ML ORAL SUSP 150ML" to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $2,209.66, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that provides a wide range of medications and medical supplies to various federal agencies, particularly the Department of Defense and the Department of...
- This federal contract award, with an ID of SPE2DB22D3011|SPE2DB24FQ0NN, was granted to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,111.35 firm fixed price delivery order is for the supply of the medication Zonisade 100 mg/5 ml oral suspension in 150 ml bottles. The contract, which has an ultimate completion date of April 12, 2024, was awarded on April 11, 2024 by the Defense Logistics Agency (DLA), a defense...
- The federal contract award summarized here is for the delivery of the pharmaceutical product "ZONISADE 100 MG/5 ML ORAL SUSP 150ML" to the Defense Logistics Agency (DLA). The contract, valued at $4,354.19, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 15, 2023. The contract is not designated with any...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,930.33, is for the delivery of ZONISADE 100 MG/5 ML ORAL SUSP 150ML, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...